{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:18:58Z","timestamp":1788434338912,"version":"build-2803163510"},"reference-count":47,"publisher":"American Chemical Society (ACS)","issue":"34","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/na","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2019-I2M5-017"],"award-info":[{"award-number":["2019-I2M5-017"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-C&T-B-082"],"award-info":[{"award-number":["2022-I2M-C&T-B-082"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2022YFA1304600"],"award-info":[{"award-number":["2022YFA1304600"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Beijing Life Science Academy","doi-asserted-by":"publisher","award":["2024300CB0100"],"award-info":[{"award-number":["2024300CB0100"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2024YFC3405400"],"award-info":[{"award-number":["2024YFC3405400"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Science Foundation","doi-asserted-by":"publisher","award":["32141003"],"award-info":[{"award-number":["32141003"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Science Foundation","doi-asserted-by":"publisher","award":["32371503"],"award-info":[{"award-number":["32371503"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["L246037"],"award-info":[{"award-number":["L246037"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Foundation of State Key Lab of Proteomics","doi-asserted-by":"publisher","award":["SKLP-C202002"],"award-info":[{"award-number":["SKLP-C202002"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Foundation of State Key Lab of Proteomics","doi-asserted-by":"publisher","award":["SKLP-K202201"],"award-info":[{"award-number":["SKLP-K202201"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Foundation of State Key Lab of Proteomics","doi-asserted-by":"publisher","award":["SKLP-O202201"],"award-info":[{"award-number":["SKLP-O202201"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules that induce selective degradation of target proteins by hijacking the ubiquitin-proteasome system (UPS). Despite their transformative potential in eliminating disease-associated proteins, comprehensively identifying off-target degradation events remains technically challenging. Here, we employed an integrated proteomic and ubiquitinomic strategy to systematically profile the degradation landscape of the PROTAC molecule dBET1 in Jurkat T cells. By capturing the upstream ubiquitination events\u2500which serve as earlier and more sensitive indicators than total protein abundance\u2500our approach enabled the identification of previously overlooked off-target candidates. While dBET1 efficiently degraded its canonical BET family targets, our data also revealed the mitochondrial outer membrane protein VDAC1 as a putative off-target, evidenced by its depletion and increased multisite ubiquitination. Notably, our analysis framework enabled site-specific resolution of degradation events within BRD3, revealing preferential ubiquitination at functionally essential bromodomains, suggesting that degron-enriched regions may underlie domain-selective degradation. Additionally, dBET1 treatment was associated with mitochondrial depolarization and calcium homeostasis disruption, defects that we hypothesize may be functionally linked to the observed VDAC1 depletion. Together, this study demonstrates that integrating ubiquitomics provides a superior sensitivity layer for PROTAC safety assessment, capable of uncovering mechanism-based liabilities that escape conventional global proteomic screening.<\/jats:p>","DOI":"10.1021\/acs.analchem.6c00787","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:15:25Z","timestamp":1787066125000},"page":"24746-24760","source":"Crossref","is-referenced-by-count":0,"title":["Integrative\nProteomics and Ubiquitomics Reveal on-Targets\nand off-Targets of PROTAC dBET1"],"prefix":"10.1021","volume":"98","author":[{"given":"Hongtao","family":"Wen","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College , , ,","place":["Beijing, China, 100050"]},{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]},{"name":"Hebei University , , ,","place":["Baoding, China, 071002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7291-722X","authenticated-orcid":true,"given":"Bendong","family":"Yang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Dai","sequence":"additional","affiliation":[{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4177-3726","authenticated-orcid":true,"given":"Yanchang","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]},{"name":"Anhui Medical University , , ,","place":["Hefei, China, 230032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-2829","authenticated-orcid":true,"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-9806","authenticated-orcid":true,"given":"Liyan","family":"Yu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-6981","authenticated-orcid":true,"given":"Ping","family":"Xu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College , , ,","place":["Beijing, China, 100050"]},{"name":"Beijing Institute of Lifeomics, Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences , , ,","place":["Beijing, China, 102206"]},{"name":"Hebei University , , ,","place":["Baoding, China, 071002"]},{"name":"China Medical University , , ,","place":["Shenyang, China, 110122"]},{"name":"Hunan University , , ,","place":["Changsha, China, 410082"]},{"name":"Anhui Medical University , , ,","place":["Hefei, China, 230032"]},{"name":"Hengyang Medical College, University of South China , , ,","place":["Hengyang, China, 421001"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"3","key":"2026090306471219000_cit1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC\nTargeted Protein Degraders:\nThe Past Is Prologue","volume":"21","author":"Be\u0301ke\u0301s","year":"2022","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"2","key":"2026090306471219000_cit2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced\nProtein Degradation: An Emerging Drug Discovery\nParadigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"15","key":"2026090306471219000_cit3","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: Chimeric\nMolecules That Target Proteins to\nthe Skp1\u2013Cullin\u2013F Box Complex for Ubiquitination and\nDegradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"2026090306471219000_cit4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing\nTargeted Protein Degradation\nfor Cancer Therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"2026090306471219000_cit5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/1535-7163.MCT-20-0599","article-title":"Targeting STAT3 with Proteolysis\nTargeting Chimeras (PROTACs) and next Generation Antisense Oligonucleotides","volume":"20","author":"Shiah","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"2026090306471219000_cit6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting\nTranscription Factors in Cancer\u2013from Undruggable to Reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"2026090306471219000_cit7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic\nin Vivo Protein Knockdown by Small-Molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"2026090306471219000_cit8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/anie.201507634","article-title":"Modular PROTAC Design for the Degradation\nof Oncogenic BCR-ABL","volume":"55","author":"Lai","year":"2016","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026090306471219000_cit9","unstructured":"ClinicalTrials.gov.\n          \n          https:\/\/clinicaltrials.gov\/ (accessed July 2025)."},{"key":"2026090306471219000_cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108437","article-title":"Recent Advances in\nPROTAC-Based Antiviral and Antibacterial\nTherapeutics","volume":"160","author":"Zhou","year":"2025","journal-title":"Bioorg. Chem."},{"key":"2026090306471219000_cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114112","article-title":"Targeting Androgen\nReceptor Degradation with PROTACs from Bench to\nBedside","volume":"158","author":"Jia","year":"2023","journal-title":"Biomed. Pharmacother"},{"key":"2026090306471219000_cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107234","article-title":"PROTACs Targeting\nAndrogen Receptor Signaling: Potential Therapeutic Agents for Castration-Resistant\nProstate Cancer","volume":"205","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"32","key":"2026090306471219000_cit13","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1080\/14796694.2024.2377530","article-title":"VERITAC-2: A Phase III Study of Vepdegestrant, a PROTAC\nER Degrader, versus Fulvestrant in ER+\/HER2- Advanced Breast Cancer","volume":"20","author":"Hamilton","year":"2024","journal-title":"Future Oncol."},{"issue":"6682","key":"2026090306471219000_cit14","doi-asserted-by":"publisher","DOI":"10.1126\/science.adi5798","article-title":"Kinase-Impaired BTK Mutations Are Susceptible to Clinical-Stage\nBTK and IKZF1\/3 Degrader NX-2127","volume":"383","author":"Montoya","year":"2024","journal-title":"Science"},{"issue":"1","key":"2026090306471219000_cit15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/d41573-023-00197-4","article-title":"PROTAC in\nClinic for Autoimmune Skin Disease","volume":"23","author":"Eccleston","year":"2024","journal-title":"Nat. Rev.\nDrug Discovery"},{"issue":"12","key":"2026090306471219000_cit16","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100689","article-title":"Strategies to Reduce the On-Target\nPlatelet Toxicity\nof Bcl-xL Inhibitors: PROTACs, SNIPERs and Prodrug-Based Approaches","volume":"23","author":"Negi","year":"2022","journal-title":"Chem. Bio. Chem."},{"key":"2026090306471219000_cit17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC Design\nfrom Selective Degradation with a Promiscuous\nWarhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"26","key":"2026090306471219000_cit18","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-Induced\nBET Protein Degradation as a Therapy for Castration-Resistant Prostate\nCancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090306471219000_cit19","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cell.2020.10.038","article-title":"Mapping\nthe degradable kinome provides a resource for expedited degrader development","volume":"183","author":"Donovan","year":"2020","journal-title":"Cell"},{"issue":"25","key":"2026090306471219000_cit20","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2006.07.4658","article-title":"What Is\nthe Right Dose? The Elusive Optimal Biologic Dose in Phase I Clinical\nTrials","volume":"24","author":"Adjei","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"2026090306471219000_cit21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1111\/bph.15014","article-title":"Proteolysis-targeting\nchimeras in drug development: A safety perspective","volume":"177","author":"Moreau","year":"2020","journal-title":"British Journal of Pharmacology."},{"issue":"1","key":"2026090306471219000_cit22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95354-3","article-title":"A Proteomic\nPlatform to Identify Off-Target Proteins Associated with Therapeutic\nModalities That Induce Protein Degradation or Gene Silencing","volume":"11","author":"Liu","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"2026090306471219000_cit23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the Dependency of Cellular Protein\nLevels on mRNA Abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"issue":"7","key":"2026090306471219000_cit24","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1021\/acscentsci.0c00049","article-title":"Native Mass Spectrometry Can Effectively Predict PROTAC\nEfficacy","volume":"6","author":"Beveridge","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"4","key":"2026090306471219000_cit25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/2472555220985776","article-title":"The Vital Role of\nProteomics in Characterizing Novel\nProtein Degraders","volume":"26","author":"Zhang","year":"2021","journal-title":"SLAS Discovery"},{"issue":"4","key":"2026090306471219000_cit26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","article-title":"An Expanded Lexicon\nfor the Ubiquitin Code","volume":"24","author":"Dikic","year":"2023","journal-title":"Nat. Rev. Mol. Cell\nBiol."},{"issue":"10","key":"2026090306471219000_cit27","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/nprot.2013.120","article-title":"Large-Scale\nIdentification\nof Ubiquitination Sites by Mass Spectrometry","volume":"8","author":"Udeshi","year":"2013","journal-title":"Nat. Protoc."},{"issue":"2","key":"2026090306471219000_cit28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","article-title":"Systematic and Quantitative\nAssessment of the Ubiquitin-Modified Proteome","volume":"44","author":"Kim","year":"2011","journal-title":"Mol. Cell"},{"issue":"1","key":"2026090306471219000_cit29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41467-020-20509-1","article-title":"Data-Independent\nAcquisition Method for Ubiquitinome Analysis Reveals Regulation of\nCircadian Biology","volume":"12","author":"Hansen","year":"2021","journal-title":"Nat. Commun."},{"issue":"6241","key":"2026090306471219000_cit30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide Conjugation as a Strategy\nfor in Vivo Target Protein Degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"issue":"1","key":"2026090306471219000_cit31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone Recognition and Large-Scale Structural Analysis of the Human\nBromodomain Family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"2026090306471219000_cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2025.129077","article-title":"A High-Throughput Method for Specific,\nRapid, Precise and Efficient\nDetection of Protein Ubiquitination Using ThUBD-Coated High-Density\n96-Well Plates","volume":"299","author":"Liu","year":"2026","journal-title":"Talanta"},{"issue":"6414","key":"2026090306471219000_cit33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat0572","article-title":"Defining\nthe Human C2H2 Zinc Finger Degrome Targeted by Thalidomide Analogs\nthrough CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science"},{"issue":"2","key":"2026090306471219000_cit34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative\nProteomics of the Cancer Cell Line Encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"issue":"14","key":"2026090306471219000_cit35","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1021\/ac0498563","article-title":"A Model for Random Sampling and Estimation\nof Relative Protein Abundance in Shotgun Proteomics","volume":"76","author":"Liu","year":"2004","journal-title":"Anal. Chem."},{"issue":"1","key":"2026090306471219000_cit36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/acs.jproteome.7b00170","article-title":"Gentle Introduction\nto the Statistical Foundations of False Discovery Rate in Quantitative\nProteomics","volume":"17","author":"Burger","year":"2018","journal-title":"J. Proteome Res."},{"key":"2026090306471219000_cit37","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014:\nmutations,\nPTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic acids research."},{"issue":"41","key":"2026090306471219000_cit38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado6492","article-title":"Mechanism\nof Degrader-Targeted Protein Ubiquitinability","volume":"10","author":"Crowe","year":"2024","journal-title":"Sci. Adv."},{"issue":"8","key":"2026090306471219000_cit39","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1073\/pnas.1909814117","article-title":"Decision between\nMitophagy and Apoptosis by Parkin via VDAC1 Ubiquitination","volume":"117","author":"Ham","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"2026090306471219000_cit40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41557-023-01379-8","article-title":"Proteolysis-Targeting\nChimeras with Reduced off-Targets","volume":"16","author":"Nguyen","year":"2024","journal-title":"Nat. Chem."},{"issue":"1","key":"2026090306471219000_cit41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cell.2018.02.030","article-title":"Multiplexed Proteome Dynamics Profiling Reveals Mechanisms\nControlling Protein Homeostasis","volume":"173","author":"Savitski","year":"2018","journal-title":"Cell"},{"issue":"7370","key":"2026090306471219000_cit42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition\nof BET Recruitment to Chromatin as an Effective Treatment for MLL-Fusion\nLeukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"2026090306471219000_cit43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, Mitochondrial\nDysfunction, and Alzheimer\u2019s Disease","volume":"131","author":"Shoshan-Barmatz","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"11","key":"2026090306471219000_cit44","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","article-title":"Mitochondria at the Crossroads of\nHealth and Disease","volume":"187","author":"Suomalainen","year":"2024","journal-title":"Cell"},{"issue":"6255","key":"2026090306471219000_cit45","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1126\/science.aac7516","article-title":"Mutations\nCausing Mitochondrial Disease:\nWhat Is New and What Challenges Remain?","volume":"349","author":"Lightowlers","year":"2015","journal-title":"Science"},{"issue":"1","key":"2026090306471219000_cit46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial Dynamics in Health\nand Disease: Mechanisms and Potential Targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduction Targeted Ther."},{"issue":"D1","key":"2026090306471219000_cit47","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","article-title":"iProX: an integrated proteome resource","volume":"47","author":"Ma","year":"2019","journal-title":"Nucleic acids research"}],"container-title":["Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.analchem.6c00787","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/98\/34\/24746\/66812323\/acs.analchem.6c00787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/98\/34\/24746\/66812323\/acs.analchem.6c00787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:47:21Z","timestamp":1788432441000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancham\/article\/98\/34\/24746\/5272948\/Integrative-Proteomics-and-Ubiquitomics-Reveal-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":47,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2026,8,18]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.analchem.6c00787","relation":{},"ISSN":["0003-2700","1520-6882"],"issn-type":[{"value":"0003-2700","type":"print"},{"value":"1520-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}